Purevax RC
vaccine against feline viral rhinotracheitis and feline calicivirosis
Table of contents
Overview
Purevax RC is a veterinary vaccine used to protect cats from the age of 8 weeks against feline viral rhinotracheitis (a flu-like illness caused by a herpesvirus) and feline calicivirosis (a flu-like illness with inflammation of the mouth caused by a calicivirus). The vaccine helps to reduce the symptoms of the diseases.
Purevax RC contains attenuated (weakened) feline rhinotracheitis herpesvirus (FHV F2 strain) and inactivated (killed) calicivirosis antigens (FCV 431 and G1 strains) as active substance.
Authorisation details
Product details | |
---|---|
Name |
Purevax RC
|
Agency product number |
EMEA/V/C/000091
|
Active substance |
|
International non-proprietary name (INN) or common name |
vaccine against feline viral rhinotracheitis and feline calicivirosis
|
Species |
Cats
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI06AH08
|
Publication details | |
---|---|
Marketing-authorisation holder |
Boehringer Ingelheim Vetmedica GmbH
|
Revision |
16
|
Date of issue of marketing authorisation valid throughout the European Union |
23/02/2005
|
Contact address |
55216 Ingelheim am Rhein |
Product information
17/02/2022 Purevax RC - EMEA/V/C/000091 - WS2201/0027
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Immunologicals for felidae
Therapeutic indication
Active immunisation of cats aged eight weeks and older:
- against feline viral rhinotracheitis to reduce clinical signs;
- against calicivirus infection to reduce clinical signs.
Onsets of immunity isone week after primary vaccination course.
The duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.